Human Papillomavirus (HPV) infection in men has even higher incidence than in women. It is estimated that more than 80 sexually active men contact at least one type of HPV at some point in theirlife, but these infections usually subside. However, in recent years there has been a significant increase in oropharyngeal and anus cancer attributable to HPV in men.
What is the role of men in relation to HPV infections?
While HPV infections in men generally refer to higher percentages than in women, persistent infections, injuries and cancer may occur in some cases. Also, during the period between infection and remission, men can act as vehicles of infection, spreading their sexual partners and further spreading the infection or causing re-infection.
Should men be treated against HPV?
Given the increased incidence of infections, injuries and cancer attributable to HPV in men, as well as their role as vehicles of infection and reinfection, it is critical that men be treated against HPV using currently existing therapeutic alternatives.
Is HuPaVir indicated for HPV in men?
Yes. HuPaVir has a mechanism of action that makes it equally effective for both women and men; therefore, it can be used in the treatment of HPV infections in men. It is important to keep in mind that if a man’s sexual partner has an HPV infection, then it is highly likely that he is also infected and therefore should choose to treat his infection even if there are no visible symptoms. This can prevent new infections and re-infections.
No products in the cart.
We use our own and third-party cookies to improve our services and show you advertising related to your preferences by analyzing your browsing habits. If you go on surfing, we will consider you accepting its use. Accept